Published 2019
| Version v1
Publication
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein
Creators
Contributors
Others:
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/982970
- URN
- urn:oai:iris.unige.it:11567/982970